Top gainers on the Nasdaq in today’s session are: Stock Name Price Change (%) Moderna Inc $25.14 +6.28% Fiserv $166.45 +4.60% Illumina $83.61 +3.35%
Latest News
Getting the most out of your 401(k) by following these guidelines
00:00 Brad According to a Yahoo Finance Harris poll, banked households in America are not enthusiastic about the money they have saved. Only 10%
Federal Reserve to slash staff by 10% over several years
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The Federal Reserve has
Minnesota pensions embraced investing in private equity, a big risk that’s paid off
The State Board of Investment is made up of Gov. Tim Walz, state Auditor Julie Blaha, Secretary of State Steve Simon, and Attorney General
5 Questions to Ask Before Investing in Humanoid Robots
Humanoid robots are advancing rapidly due to generative AI, mechatronics, and simulation technology, making them suitable for industries like manufacturing, healthcare, and hospitality. Executives
Building Legacy Brick By Brick: Lessons On Real Estate Investing For Family Offices
In today’s evolving market, the difference between building a legacy through real estate and suffering loss lies in proactive strategy and disciplined execution.
What to make of the stock market’s recovery
Putting a number on how much in Social Security might be garnished to repay student loans; coverage of the bond market; and whether or
Minnesota pensions embraced investing in private equity, a big risk that’s paid off
Like funds across the country, Minnesota increased its investments after the Great Recession. The $96 billion combined funds are invested on behalf of about
Stock Market Gains Accelerate as S&P Goes for Best Week Since April Tariff Rollback
The stock market was picking up steam on Friday with the major indexes on track for their best week since President Donald Trump delayed
Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges
Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to support a smooth transition to